DNTH vs MCD · rev $6.2M vs P/E 23, rev $25.92B
Dianthus Therapeutics Inc. (DNTH) versus McDonald’s Corporation (MCD) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
McDonald’s Corporation (MCD) is a restaurants company listed on NYSE. It is led by Chris Kempczinski.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported MCD revenue for 2024-12-31 was $25.92B. Net income was $8.22B. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
DNTH currently screens at market cap $4.40B. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
Not investment advice. Open the DNTH and MCD stock pages for the full models.
Not investment advice.